Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1991-10-16
pubmed:abstractText
Cepharanthine, isolated from Stephania cepharantha, is one of the bisbenzylisoquinoline-type alkaloids. We have found that it inhibits tumor promotion after topical application in two-stage carcinogenesis in mouse skin. Epidermal ornithine decarboxylase activities inhibited by topical application of cepharanthine, with an 5 micrograms/mouse) and mezerein (5 micrograms/mouse) were found to be inhibited by topical application of cepharanthine, with a ED50 of 1.2 mumol and 1.4 mumol respectively. These inhibitory effects of cepharanthine are considered to be related to its antitumor activity in two-stage carcinogenesis in mouse skin. Cell-mediated immunosuppression by TPA was unaffected by topical application of cepharanthine. A diet containing 0.005% cepharanthine (about 0.5 mg mouse-1 day-1) slightly suppressed the two-stage promotion of skin tumors by twice-weekly applications of 2.5 micrograms TPA for 2 weeks (first stage) followed by twice-weekly applications of 2.5 micrograms mezerein for 23 weeks (second stage) in ICR mice following initiation by 50 micrograms 7,12-dimethylbenz[a]anthracene. Oral administration of cepharanthine inhibits the tumor promotion in two-stage carcinogenesis in mouse skin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0171-5216
pubmed:author
pubmed:issnType
Print
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
421-4
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1909698-9,10-Dimethyl-1,2-benzanthracene, pubmed-meshheading:1909698-Administration, Oral, pubmed-meshheading:1909698-Administration, Topical, pubmed-meshheading:1909698-Alkaloids, pubmed-meshheading:1909698-Animals, pubmed-meshheading:1909698-Benzylisoquinolines, pubmed-meshheading:1909698-Carcinogens, pubmed-meshheading:1909698-Diterpenes, pubmed-meshheading:1909698-Drug Interactions, pubmed-meshheading:1909698-Enzyme Induction, pubmed-meshheading:1909698-Female, pubmed-meshheading:1909698-Immunity, Cellular, pubmed-meshheading:1909698-Mice, pubmed-meshheading:1909698-Mice, Inbred ICR, pubmed-meshheading:1909698-Ornithine Decarboxylase, pubmed-meshheading:1909698-Skin, pubmed-meshheading:1909698-Skin Neoplasms, pubmed-meshheading:1909698-Terpenes, pubmed-meshheading:1909698-Tetradecanoylphorbol Acetate
pubmed:year
1991
pubmed:articleTitle
Cepharanthine inhibits two-stage tumor promotion by 12-O-tetradecanoylphorbol 13-acetate and mezerein on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene.
pubmed:affiliation
College of Pharmacy, Nihon University, Chiba, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't